| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07473960 IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia |
Enrollment closed, study ongoing |
| 2026-08-14 | NCT07265258 A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease |
Recruitment opened |
| 2026-08-14 | NCT07265258 A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease |
date change Primary completion pushed: 2026-09-12 -> 2028-06-30 |
| 2026-08-14 | NCT07265258 A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease |
date change Completion pushed: 2027-09-04 -> 2028-12-30 |
| 2026-08-11 | NCT07722494 IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer |
Recruitment opened |
| 2026-07-30 | NCT06081920 A Study of IBI363 in Subjects With Advanced Melanoma |
Enrollment increased: 150 -> 180 participants |
| 2026-07-30 | NCT06081920 A Study of IBI363 in Subjects With Advanced Melanoma |
date change Primary completion pushed: 2025-06-06 -> 2028-10-19 |
| 2026-07-30 | NCT06081920 A Study of IBI363 in Subjects With Advanced Melanoma |
date change Completion pushed: 2026-07-31 -> 2028-10-19 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07764861 A Open-Label Phase in Participants With Multiple Myeloma | Phase 2 | Not Yet Recruiting |
| 2026-08-14 | NCT07765160 Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants | Phase 1 | Not Yet Recruiting |
| 2026-08-10 | NCT07754786 A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants… | Phase 3 | Not Yet Recruiting |
| 2026-07-23 | NCT07722494 IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer | Phase 3 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07265258 | A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease | Thyroid Eye Disease | Recruiting |
| Phase 3 | |||
| NCT06834672 | Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With… | Ovarian | Recruiting |
| NCT06931028 | A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2 | Sleep Apnea | Recruiting |
| NCT07066098 | A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously… | Pancreatic Cancer | Recruiting |
| NCT07113262 | A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive… | Thyroid Eye Disease | Recruiting |
| NCT07255209 | A Study of IBI362 in Chinese Adolescents With Obesity or Overweight | Adolescents With Obesity or Overweight With Weight-Related Comorbidities | Recruiting |
| NCT07469800 | Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity | Overweight | Recruiting |
| NCT07722494 | IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer | Colorectal Cancer | Recruiting |
| NCT06164873 | A Study of IBI362 9 mg in Chinese Adults With Obesity | Obesity | Active, Not Recruiting |
| NCT05972473 | A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD | Neovascular Age-related Macular Degeneration | Active, Not Recruiting |
| NCT05116462 | Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT06884293 | A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With… | Overweight | Active, Not Recruiting |
| NCT06238843 | A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's… | Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Active, Not Recruiting |
| NCT05890742 | A Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With… | MSI-H | Active, Not Recruiting |
| NCT07623798 | A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003 | Relapsed or Refractory Multiple Myeloma | Not Yet Recruiting |
| NCT07754786 | A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants… | Atopic Dermatitis | Not Yet Recruiting |
| NCT07473960 | IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia | Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia | Active, Not Recruiting |
| Phase 2 | |||
| NCT06281678 | A Study of IBI363 in Subjects with Advanced Solid Malignancies | Melanoma | Recruiting |
| NCT06797297 | A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to… | Melanoma | Recruiting |
| NCT06862908 | A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity | Obesity | Recruiting |
| NCT06937749 | A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis… | Metabolic Dysfunction-associated Steatohepatitis (MASH) | Recruiting |
| NCT07399067 | A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis | Atopic Dermatitis | Recruiting |
| NCT07330934 | A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe… | Atopic Dermatitis | Recruiting |
| NCT07483567 | IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of… | CLDN18.2 Positive | Recruiting |
| NCT07483554 | IBI343 in Combination Therapy for Advanced Malignant Solid Tumors | CLDN18.2 Positive | Recruiting |